The TGFBR2 gene is mutated in several cancer types with ∼90% of colon cancers characterized by MMR deficiency displaying frameshift mutations in a polyadenine tract of TGFBR2, which encodes the signal peptide of the expressed protein (Parsons et al, 1995). This evidence concerns the gene TGFBR2 and colonic neoplasm.